Zoetis Quarterly Cash Flow Statement
NYSE: ZTSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:03 PM ET · Delayed 15 min
Pre-market: 74.64 -0.17%
Zoetis free cash flow
In the quarter ended Jun 30, 2026, Zoetis generated $655.0 million of operating cash flow and spent $117.0 million on capital expenditures. That left free cash flow of $538.0 million, a free-cash-flow margin of 21.8% of revenue. Free cash flow was up 17.2% from the prior year's $459.0 million.
Zoetis returned $807.0 million to shareholders: $223.0 million in dividends and $584.0 million in share repurchases, equal to 150% of free cash flow. Free cash flow covered dividend payments 2.4 times.
Summary generated from market data by MetaCap's automated system. Methodology
Zoetis cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 691.00M | 601.00M | 603.00M | 721.00M | 726.00M | 602.00M | 581.00M | 692.00M | 624.00M | 599.00M | 523.00M | 596.00M |
| Net Income growth (YoY) | -4.82% | -0.17% | +3.79% | +4.19% | +16.35% | +0.50% | +11.09% | +16.11% | -6.87% | +8.71% | +13.70% | +12.88% |
| Depreciation & Amortization | 119.00M | 119.00M | 121.00M | 124.00M | 124.00M | 119.00M | 123.00M | 121.00M | 127.00M | 126.00M | 126.00M | 124.00M |
| Stock-Based Compensation | 26.00M | 25.00M | 22.00M | 22.00M | 22.00M | 17.00M | 19.00M | 18.00M | 19.00M | 18.00M | 17.00M | 17.00M |
| Change in Working Capital | -92.00M | -458.00M | 135.00M | -58.00M | -185.00M | -361.00M | 316.00M | 110.00M | -83.00M | -247.00M | 228.00M | -90.00M |
| Operating Cash Flow | 655.00M | 401.00M | 893.00M | 891.00M | 605.00M | 515.00M | 905.00M | 951.00M | 502.00M | 595.00M | 897.00M | 724.00M |
| Capital Expenditures | -117.00M | -110.00M | -161.00M | -136.00M | -146.00M | -178.00M | -216.00M | -167.00M | -132.00M | -140.00M | -198.00M | -145.00M |
| Investing Cash Flow | -300.00M | -87.00M | -166.00M | -167.00M | -212.00M | -203.00M | 126.00M | -178.00M | -132.00M | -131.00M | -210.00M | -271.00M |
| Dividends Paid | -223.00M | -224.00M | -220.00M | -222.00M | -223.00M | -224.00M | -194.00M | -197.00M | -197.00M | -198.00M | -172.00M | -173.00M |
| Share Repurchases | -584.00M | -606.00M | -2.06B | -394.00M | -338.00M | -443.00M | -553.00M | -433.00M | -533.00M | -339.00M | -235.00M | -250.00M |
| Debt Repaid | — | — | 0 | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | -813.00M | -840.00M | -495.00M | -134.00M | -564.00M | -677.00M | -745.00M | -628.00M | -763.00M | -524.00M | -397.00M | -416.00M |
| Net Change in Cash | -465.00M | -509.00M | 228.00M | 579.00M | -150.00M | -332.00M | 273.00M | 140.00M | -401.00M | -66.00M | 287.00M | 37.00M |
| Free Cash Flow | 538.00M | 291.00M | 732.00M | 755.00M | 459.00M | 337.00M | 689.00M | 784.00M | 370.00M | 455.00M | 699.00M | 579.00M |
This table shows 12 quarterly periods of Zoetis's cash flow statement, from Q2 2026 back to Q3 2023, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ZTS's reporting calendar. What is a cash flow statement?